Thu, 11/26/2020 | News

AusVaxSafety commences routine monitoring of meningococcal B vaccine

The AusVaxSafety active vaccine safety surveillance system has commenced routine monitoring of the safety of meningococcal B vaccine (Bexsero®) in all ages as at 1 July. This vaccine is funded under the National Immunisation Program (NIP) for Aboriginal and Torres Strait Islander children at 2, 4, 6, and 12 months of age, with a catch-up available for all Aboriginal and Torres Strait Islander children under 2 years of age until 30 June 2023, and also for people of any age with medical conditions that increase their risk of invasive meningococcal disease. 

Vaccine safety results for Bexsero® are available on the AusVaxSafety website and are updated fortnightly. 

AusVaxSafety monitors the safety of vaccines in Australia. Using de-identified data reported directly from people receiving the vaccines (or their parent or carer), AusVaxSafety monitors adverse events following immunisation and facilitates early detection of potential vaccine safety issues.

View the safety data here